Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998
Alzheimers Disease with Asymmetric Parietal Lobe Atrophy: A Case Report
J Neurol Sci 160:96-99, Kaida,K.-I.,et al, 1998
Preclinical Prediction of Alzheimer's Disease Using SPECT
Neurol 50:1563-1571, Johnson,K.A.,et al, 1998
Nonsteroidal Anti-Inflammatory Drug use and Alzheimer-Type Pathology in Aging
Neurol 50:986-990, Mackenzie,I.&Munoz,D.G., 1998
A Permanent Pure Amnestic Syndrome of Isidious Onset Related to Alzheimer's Disease
Ann Neurol 43:526-530, Didic,M.,et al, 1998
Longitudinal Study of CSF Levels of Tau, A beta 1-40, and A beta 1-42 (43) in Alzheimer's Disease
Ann Neurol 44:17-26, 61998., Kanai,M.,et al, 1998
Ginkgo Biloba for Dementia
The Medical Letter 40:63-64, , 1998
Metrifonate Benefits Cognitive, Behvioral, and Global Function in Patients with Alzheimer's Disease
Neurol 50:1222-1230, 12031998., Morris,J.C.,et al, 1998
Metrifonate Treatment of the Cognitive Deficits of Alzheimer's Disease
Neurol 50:1214-1221, 12031998., Cummings,J.L.,et al, 1998
Estrogen-replacement Therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging
Neurol 50:996-1002, Baldereschi,M.,et al, 1998
Hypothalamic Activation in Cluster Headache Attacks
Lancet 352:275-278, 2531998., May,A.,et al, 1998
Serotonin Inhibits Trigeminal Nucleus Act Evoked by Craniovasc Stim Through a 5HT 1B/1D Receptor:Cent Act in Migraine
Ann Neurol 43:711-718, Goadsby,P.J.,et al, 1998
Clinicopath Conf
Subacute Sclerosing Panencephalitis, Case 15-1998, NEJM 338:1448-1456998., , 1998
Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998
The Risk of Parkinson's Disease with Exposure to Pesticides, Farming, Well Water, and Rural Living
Neurol 50:1346-1350, Gorell,J.M.,et al, 1998
MR Differential Diagnosis of Normal-Pressure Hydrocephalus and Alzheimer Disease:Significance of Perihippocampal Fissures
AJNR 19:813-819, Holodny,A.I.,et al, 1998
New Neuropathological Criteria for Alzheimer Disease
Arch Neurol 55:1174-1176, Hyman,B.T., 1998
Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998
Serum S-100 and Neuron-Specific Enolase for Prediction of Regaining Consciousness After Global Cerebral Ischemia
Stroke 29:2363-2366, Martens,P.,et al, 1998
Inherited Prothrombotic States and Ischaemic Stroke in Childhood
JNNP 65:508-511, Ganesan,V.,et al, 1998
The Efficacy of Ginkgo Biloba on Cognitive Function in Alzheimer Disease
Arch Neurol 55:1409-1415, Oken,B.S.,et al,, 1998
Risk of Cerebral Sinus Thrombosis in Oral Contraceptive Users Who Are Carriers of Hered Prothrombotic Cond
BMJ 316:589-592, deBruijn,S.F.T.M.,et al, 1998
The APOE-e4 Allele and the Risk of Alzheimer Disease Among AFrican Americans, Whites and Hispanics
JAMA 279:751-755, 7881998., Tang,M.,et al, 1998
Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
NEJM 338:506-511, Mayeux,R.,et al, 1998
A 24-Week, Double-Blind, Placebo-Controlled Trial of Donepezil in Pts with Alzheimer's Disease
Neurol 50:136-145, Rogers,S.,et al, 1998
A Clinical Role for 99mTC-HMPAO SPECT in the Investigation of Dementia
JNNP 64:306-313, Talbot,P.R.,et al, 1998
The Genetics of Alzheimer Disease, Current Status and Future Prospects
Arch Neurol 55:294-296, Blacker,D.&Tanzi,R.E., 1998
Drop the Alzheimer's Drop Test
Neurol 50:588-591, Kardon,R.H., 1998
Diagnosis and Treatment of Alzheimer Disease and Related Disorders
JAMA 278:1363-1371, Small,G.W.,et al, 1997
A Placebo-Controlled, Double-Blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
JAMA 278:1327-1332, LeBars,P.L.,et al, 1997
Persistent Vegetative State in Alzheimer Disease
Arch Neurol 54:1382-1384, Volicer,L.,et al, 1997
Preexisting Dementia in Stroke Patients, Baseline Frequency, Associated Factors, & Outcome
Stroke 28:2429-2436, Henon,H.,et al, 1997
An Update on Primary Drug Therapies for Alzheimer Disease
Arch Neurol 54:1406-1409, Knopman,D.S.&Morris,J.C., 1997
Clinical Experience with Donepezil Hydrochloride:A Case Study Perspective
Advan Therapy 14:305-311, Geldmacher,D.S., 1997
Evaluation of Dementia:A Systematic Study of the Usefulness of the AAN Practice parameters
Neurol 49:925-935, Chui,H.&Zhang,Q., 1997
Imaging the Brain in Dementia:Expensive and Futile
AJNR 18:1847-1850, George,A.E.,et al, 1997
Complete Genomic Screen in Late-Onset Familial Alzheimer Disease, Evidence for a New Locus on Chromosome 12
JAMA 278:1237-1241, 12821997., Pericak-Vance,M.A.,et al, 1997
Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997
The Effect of Different Diagnostic Criteria on the Prevalence of Dementia
NEJM 337:1667-1674, Erkinjuntti,T.,et al, 1997
Genetic Testing for Alzheimer Disease, Practical and Ethical Issues
Arch Neurol 54:1226-1229, Roses,A.D., 1997
Herpes Simplex Virus Type 1 in Brain and Risk of Alzheimer's Disease
Lancet 349:241-244, Itzhaki,R.F.,et al, 1997
Response of the Pupil to Tropicamide is not a Reliable Test of Alzheimer Disease
Arch Neurol 54:155-159, FitzSimon,J.S.,et al, 1997
Risk of Alzheimer's Disease and Duration of NSAID Use
Neurol 48:626-632, Stewart,W.F.,et al, 1997
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Clin Features of Early-Onset Alzheimer Disease in Large Kindred with an E280A Presenilin-1 Mutation
JAMA 277:793-799, Lopera,F.,et al, 1997
Weight Loss in People with Alzheimer's Disease:A Prospective Population Based Analysis
BMJ 314:178-179, Cronin-Stubbs,D.,et al, 1997
Drug Treatment of Alzheimer's Disease, Raise Clinical and Ethical Problems
BMJ 314:693-694, Kelley,C.A.,et al, 1997
Acute Ischemic Strokes Improving During the First 48 Hours of Onset:Predictability, Outcome & Possible Mechanisms
Stroke 28:10-14, Toni,D.,et al, 1997
Apolipoprotein E Genotypes in Primary Progressive Aphasia
Neurol 49:51-55, Mesulam,M.M.,et al, 1997
What Are the Obstacles for an Accurate Clinical Diagnosis of Pick's Disease
Neurol 49:62-69, Litvan,I.,et al, 1997